Status: Recruiting
Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults
This is a single ascending dose study of L608 in healthy participants and is being conducted to evaluate the safety of L608 with dose level ranging from 10 μg to 20 μg.
Participants needed: 40
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Pharmosa Biopharm Inc.Updated: Jul 22, 2026Locations: 1
Eligibility criteria
Men and women aged between 18 and 65 (inclusive) at the time of Screening visit. [+3]
Participants with contraindications or sensitivity to any components of the stud... [+12]